Showing results (201-210 of 232) with videos related to
Sort By:
Pageof 24
Journal of the National Comprehensive Cancer Network : JNCCN|March 8, 2008
NCCN Task Force Report. prevention and management of mucositis in cancer careWilliam Bensinger, Mark Schubert, Kie-Kian Ang, et al.Neurology|December 24, 2010
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyE Pegoraro, E P Hoffman, L Piva, et al.Head & Neck|May 4, 2004
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerAthanassios Argiris, Kerstin M Stenson, Bruce E Brockstein, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2008
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levelsJ K Salama, K M Stenson, E O Kistner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.Journal of Muscle Research and Cell Motility|October 1, 1996
The myosin filament XV assembly: contributions of 195 residue segments of the myosin rod and the eight C-terminal residuesP K Chowrashi, S M Pemrick, S Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancerE E Vokes, M S Kies, D J Haraf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerFred R Rosen, Daniel J Haraf, Merrill S Kies, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.Pageof 24